OmniActive Health Sets Up New R&D Facility at Biocommons Research Park in Canada

By Sujata Garud

TMCnet Contributor

 

OmniActive Health Technologies has inaugurated a new advanced research and development facility at Biocommons Research Park in Charlottetown. The development of this station at the BioCommons Research Park in Charlottetown opens up an exciting world of opportunities for OmniActive.

Through this R&D facility, OmniActive will develop new products and technology based on solid scientific research for its customers.

This facility was inaugurated by Minister of Innovation and Advanced Learning for the Province of Prince Edward Island on June 27, 2012. The announcement related to the state-of-the-art facility was made in a joint press conference by Premier Robert Ghiz and OmniActive's Managing Director Sanjaya Mariwala, held at "The Taj Mahal Palace" in Mumbai, India.

"Prince Edward Island, being the hub for research on nutrition in Canada, offers excellent infrastructure facilities and skilled scientists," said Dr. Jayant Deshpande, chief technical officer at OmniActive Health Technology. "OmniActive's quest for innovations in nutrition health science is greatly supported by provincial and federal government agencies."

OmniActive Health Technologies supplies a range of innovative, scientifically validated, active natural ingredients for healthcare, food and personal care applications. The company has a wholly-owned U.S. subsidiary, OmniActive Health Technologies Inc., in Morristown, N.J.

OmniActive's manufacturing facilities are certified for the quality and food safety management systems under ISO-22000(2005) and cGMP standards.

During the inauguration function, the Honorable Gail Shea, Federal Minister of National Revenue, highlighted that Atlantic Canda and PEI, in particular, has a growing BioScience Community with the potential to be a world icon in this industry.

Minister Shea added that OmniActive is an excellent fit in the region's community here, and he looks forward to them growing from a research facility to full commercialization.